Literature DB >> 23658257

Rapid molecular detection of macrolide resistance in the Mycobacterium avium complex: are we there yet?

Sara Christianson1, William Grierson, Joyce Wolfe, Meenu K Sharma.   

Abstract

Macrolides are an important tool in the treatment of Mycobacterium avium complex infections. Here, we evaluate the use of 23S rRNA gene sequencing for the rapid detection of macrolide resistance. Routine sequencing of the 23S rRNA gene is highly specific for macrolide resistance but lacks in sensitivity.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23658257      PMCID： PMC3697665          DOI： 10.1128/JCM.00555-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Molecular basis of clarithromycin-resistance in Mycobacterium avium intracellulare complex.

Authors:  M A Jamal; S Maeda; N Nakata; M Kai; K Fukuchi; Y Kashiwabara
Journal:  Tuber Lung Dis       Date:  2000

Review 2.  Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1997-08       Impact factor: 21.405

3.  Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population.

Authors:  A Meier; L Heifets; R J Wallace; Y Zhang; B A Brown; P Sander; E C Böttger
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

4.  Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.

Authors:  David E Griffith; Barbara A Brown-Elliott; Brett Langsjoen; Yansheng Zhang; Xi Pan; William Girard; Kenwyn Nelson; James Caccitolo; Julio Alvarez; Sara Shepherd; Rebecca Wilson; Edward A Graviss; Richard J Wallace
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

5.  Evaluation of a rapid detection method of clarithromycin resistance genes in Mycobacterium avium complex isolates.

Authors:  Takayuki Inagaki; Tetsuya Yagi; Kazuya Ichikawa; Taku Nakagawa; Makoto Moriyama; Kei-ichi Uchiya; Toshiaki Nikai; Kenji Ogawa
Journal:  J Antimicrob Chemother       Date:  2011-02-03       Impact factor: 5.790

6.  Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.

Authors:  A Meier; P Kirschner; B Springer; V A Steingrube; B A Brown; R J Wallace; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease.

Authors:  K A Nash; C B Inderlied
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191
  7 in total
  3 in total

1.  Antimicrobial Susceptibility of Clinical and Environmental Mycobacterium chimaera Isolates.

Authors:  Simone Mok; Margaret M Hannan; Lars Nölke; Patrick Stapleton; Niamh O'Sullivan; Philip Murphy; Anne Marie McLaughlin; Eleanor McNamara; Margaret M Fitzgibbon; Thomas R Rogers
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

Authors:  Hee Jae Huh; Su-Young Kim; Hyang Jin Shim; Dae Hun Kim; In Young Yoo; On-Kyun Kang; Chang-Seok Ki; So Youn Shin; Byung Woo Jhun; Sung Jae Shin; Charles L Daley; Won-Jung Koh; Nam Yong Lee
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

3.  Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease.

Authors:  Seong Mi Moon; Hye Yun Park; Su-Young Kim; Byung Woo Jhun; Hyun Lee; Kyeongman Jeon; Dae Hun Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Seung-Heon Lee; Chang Ki Kim; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.